Rezolute, Inc.

Rezolute, Inc.verified

RZLT

Price:

$4.52

Market Cap:

$232.26M

Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is ...[Read more]

Industry

Biotechnology

IPO Date

2013-01-14

Stock Exchange

NASDAQ

Ticker

RZLT

The PE Ratio as of July 2024 (TTM) for Rezolute, Inc. (RZLT) is -3.96

According to Rezolute, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.96. This represents a change of 169.05% compared to the average of -1.47 of the last 4 quarters.

Rezolute, Inc. (RZLT) Historical PE Ratio (quarterly & annually)

How has RZLT PE Ratio performed in the past?

The mean historical PE Ratio of Rezolute, Inc. over the last ten years is -2.15. The current -3.96 PE Ratio has changed 18.29% with respect to the historical average. Over the past ten years (40 quarters), RZLT's PE Ratio was at its highest in in the March 2019 quarter at -0.15. The PE Ratio was at its lowest in in the March 2018 quarter at -61.50.

Quarterly (TTM)
Annual

Average

-2.15

Median

-1.81

Minimum

-5.14

Maximum

-0.58

Rezolute, Inc. (RZLT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Rezolute, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 291.17%

Maximum Annual PE Ratio = -0.58

Minimum Annual Increase = -70.54%

Minimum Annual PE Ratio = -5.14

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.9629.13%
2022-1.52-70.54%
2021-5.14291.17%
2020-1.32127.34%
2019-0.58-31.02%
2018-0.84-63.56%
2017-2.3038.75%
2016-1.66-53.87%
2015-3.6036.55%
2014-2.63-39.00%

Rezolute, Inc. (RZLT) Average PE Ratio

How has RZLT PE Ratio performed in the past?

The current PE Ratio of Rezolute, Inc. (RZLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-2.87

5-year avg

-2.10

10-year avg

-2.15

Rezolute, Inc. (RZLT) PE Ratio vs. Peers

How is RZLT’s PE Ratio compared to its peers?

Rezolute, Inc.’s PE Ratio is less than Freeline Therapeutics Holdings plc (-0.57), less than Eledon Pharmaceuticals, Inc. (-2.03), greater than Clene Inc. (-11.39), less than Reneo Pharmaceuticals, Inc. (-0.70), greater than Larimar Therapeutics, Inc. (-11.07),

Build a custom stock screener for Rezolute, Inc. (RZLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rezolute, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rezolute, Inc. (RZLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rezolute, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Rezolute, Inc.'s PE Ratio?

How is the PE Ratio calculated for Rezolute, Inc. (RZLT)?

What is the highest PE Ratio for Rezolute, Inc. (RZLT)?

What is the 3-year average PE Ratio for Rezolute, Inc. (RZLT)?

What is the 5-year average PE Ratio for Rezolute, Inc. (RZLT)?

How does the current PE Ratio for Rezolute, Inc. (RZLT) compare to its historical average?